Anna Vuorimaa - UTU Research Portal

Anna Vuorimaa

- Senior Researcher,
Clinical Neurosciences (Department of Clinical Medicine)
- Doctoral Researcher,
Department of Clinical Medicine (Faculty of Medicine)

anna.vuorimaa@utu.fi

: https://orcid.org/0000-0002-0711-6917

Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis (2025)
- Journal of Neurology, Neurosurgery and Psychiatry
Ahola, Venla; Saraste, Maija; Nylund, Marjo; Matilainen, Markus; Luoma, Amelie; Vuorimaa, Anna; Lehto, Jussi; Laaksonen, Sini; Brockmann, Eeva-Christine; Kuhle, Jens; Leppert, David; Soukka, Tero; Lamminmäki, Urpo; Airas, Laura
Predictors of risk of secondary progression in multiple sclerosis (2025)
- Therapeutic Advances in Neurological Disorders
Laaksonen, Sini; Sucksdorff, Marcus; Vuorimaa, Anna; Kuhle, Jens; Nylund, Marjo; Rajander, Johan; Wahlroos, Saara; Matilainen, Markus; Saraste, Maija; Airas, Laura
Association of serum neurofilament light with microglial activation in multiple sclerosis (2023)
- Journal of Neurology, Neurosurgery and Psychiatry
Saraste Maija, Matilainen Markus, Vuorimaa Anna, Laaksonen Sini, Sucksdorff Marcus, Leppert David, Kuhle Jens, Airas Laura
Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis (2023)
- Multiple Sclerosis and Related Disorders
Laaksonen Sini, Saraste Maija, Sucksdorff Marcus, Nylund Marjo, Vuorimaa Anna, Matilainen Markus, Heikkinen Jaakko, Airas Laura
Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis (2023)
- European Journal of Neurology
Lehto Jussi, Nylund Marjo, Matilainen Markus, Sucksdorff Marcus, Vuorimaa Anna, Rajander Johan, Wahlroos Saara, Hariri Parisa, Laura Airas
High serum neurofilament associates with diffuse white matter damage in MS (2021)
- Neurology, Neuroimmunology and Neuroinflammation
Saraste Maija, Bezukladova Svetlana, Matilainen Markus, Tuisku Jouni, Rissanen Eero, Sucksdorff Marcus, Laaksonen Sini, Vuorimaa Anna, Kuhle Jens, Leppert David, Airas Laura
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis (2020)
- Brain
Sucksdorff M, Matilainen M, Tuisku J, Polvinen E, Vuorimaa A, Rokka J, Nylund M, Rissanen E, Airas L
Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging (2020)
- Neurology, Neuroimmunology and Neuroinflammation
Svetlana Bezukladova, Jouni Tuisku, Markus Matilainen, Anna Vuorimaa, Marjo Nylund, Sarah Smith, Marcus Sucksdorff, Mehrbod Mohammadian, Virva Saunavaara, Sini Laaksonen, Johanna Rokka, Juha O. Rinne, Eero Rissanen, Laura Airas
Natalizumab treatment reduces microglial activation in the white matter of the MS brain (2019)
- Neurology, Neuroimmunology and Neuroinflammation
Sucksdorff M, Tuisku J, Matilainen M, Vuorimaa A, Smith S, Keitila J, Rokka J, Parkkola R, Nylund M, Rinne J, Rissanen E, Airas L
Positron emission tomography imaging in evaluation of MS pathology in vivo (2018)
- Multiple Sclerosis
Heidi Högel, Eero Rissanen, Anna Vuorimaa, Laura Airas
In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease (2017)
- Contrast Media and Molecular Imaging
Anna Vuorimaa, Eero Rissanen, Laura Airas